SESSION 4 - BIOMARKER DRIVEN TREATMENT

Biomarker driven treatment of selected NSCLC: EGFR - EGFR TKI in mutant EGFR NSCLC - Mechanisms of resistance and drugs in development

F. Cappuzzo